First generic pimobendan chewable tablets for canine congestive heart failure receives FDA approval

    The drug from Cronus Pharma contains the same active ingredient as Boehringer Ingelheim's Vetmedin.
    Officials with the FDA have approved pimobendan chewable tablets (Pimomedin; Cronus Pharma Specialties India) for managing signs of mild, moderate, or severe congestive heart failure in dogs caused by clinical myxomatous mitral valve disease (MMVD) or dilated cardiomyopathy (DCM). Pimobendan chewable tablets are indicated for use with concurrent therapy for congestive heart failure as appr
    This post WAS generated by Author with the help of AI .

    DVM360 is the official website for the renowned veterinary publication dvm360® magazine. As a giant in the industry, dvm360 provides veterinary professionals with comprehensive resources and information to help enhance patient care and client services. We cover every angle of veterinary medicine from recent technological advancements to clinical insights to effective managerial strategies.

    Latest articles

    Related articles

    Leave a reply

    Please enter your comment!
    Please enter your name here